M.D., Ph.D., CEO, SageMedic Corp
Christian Apfel is internationally recognized for changing medical practice by bringing innovation to millions of patients by designing and executing on highest quality clinical research. One of his most notable innovations, the “Apfel Score,” is now used in clinical practice globally. Chris has turned his attention to precision medicine and is the founder and CEO of SageMedic Corporation. SageMedic redefines precision medicine with its SAGE Direct Platform™ to help millions of cancer patients to identify the most effective treatment by overcoming limitations inherent to genome-driven targeted therapy. He has published more than 100 peer-reviewed publications and is an Adjunct Professor at UCSF. He is an investor with Life Science Angels and the chair of the life science committee at the Keiretsu Forum. Chris is a California licensed physician and received his MD/PhD from Justus-Liebig-Universität Giessen, Germany, and his an MBA from Wharton, University of Pennsylvania, PA.
Clinical & Research Tools Showcase: SageMedic Corp
SageMedic’s genome-free SAGE Direct Platform™ will help millions of patients without driver-mutations to identify the most effective treatment.
The Genome-free SAGE Direct Testing Platform™
Most cancer patients lack driver mutations or other bio-markers and therefore receive chemotherapy, which is still a hit or miss experiment. SageMedic’s genome-free SAGE Direct Platform™ will help those millions of patients to identify the most effective treatment for better outcomes.